Results 21 to 30 of about 54,150 (267)

Rhabdomyosarcoma of the uterus in an adult patient with osteopetrosis: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Uterine sarcoma accounts for 3–7% of uterine malignant neoplasms. It is more aggressive than epithelial neoplasms, and patients have a poor prognosis. Rhabdomyosarcoma is classified as a heterologous uterine sarcoma. It is the most common soft
Soheila Aminimoghaddam   +2 more
doaj   +1 more source

Chorein sensitive microtubule organization in tumor cells [PDF]

open access: yesPeerJ, 2023
Background The purpose of this study is to analyzed the involvement of chorein in microtubules organization of three types of malignant; rhabdomyosarcoma tumor cells (ZF), rhabdomyosarcoma cells (RH30), and rhabdomyosarcoma cells (RD).
Saad Alkahtani   +3 more
doaj   +2 more sources

Cell death pathways as therapeutic targets in rhabdomyosarcoma [PDF]

open access: yes, 2012
Resistance of rhabdomyosarcoma to current therapies remains one of the key issues in pediatric oncology. Since the success of most cytotoxic therapies in the treatment of cancer, for example, chemotherapy, depends on intact signaling pathways that ...
Fulda, Simone
core   +1 more source

Association of Ataxia Telangiectasia Mutated (ATM) gene mutation/deletion with Rhabdomyosarcoma

open access: yesMolecular Cancer, 2003
Background Rhabdomyosarcoma is a common malignancy in children. There are two major types of rhabdomyosarcomas, the embryonal and the alveolar, differing in cytogenetic and morphologic features.
Feramisco James R   +5 more
doaj   +1 more source

Embryonal Rhabdomyosarcoma of Prostate in Adult: A Rare Case Report

open access: yesFolia Medica Indonesiana, 2021
Rhabdomyosarcoma is the fifth most common type of soft tissue solid tumor in children and the most common in the last two decades. Rhabdomyosarcoma of the urogenital organ is a rare mesenchymal tumor, covering 22% of all Rhabdomyosarcoma cases.
Dimas Panca Andhika   +1 more
doaj   +1 more source

Orbital Rhabdomyosarcoma [PDF]

open access: yesCancer Control, 2004
Although rhabdomyosarcoma (RMS) is a rare tumor among the entire group of mesenchymal malignancies, it is a relatively common lesion and significant challenge for the ocular oncologist in terms of its diagnosis and management.A comprehensive literature search of articles published over the past 30 years in PubMed was conducted.Orbital RMS usually ...
Karcioglu, Zeynel A.   +3 more
openaire   +4 more sources

Electron microscopic, immunofluorescent and virological studies on a rhabdomyosarcoma in epidermodysplasia verruciformis [PDF]

open access: yes, 1971
A subcutaneous tumor of a patient with epidermodysplasia verruciformis was studied by the light microscopy, the electronmicroscopy and the immunofluorescent test.
Koyama, Hiroko, Yabe, Yoshiro
core   +1 more source

BLADDER EMBRYONAL RHABDOMYOSARCOMA IN AN 18-MONTHS-OLD BOY: A CASE REPORT

open access: yesJurnal Urologi Indonesia, 2023
Objective: This study aims to report a case of bladder embryonal rhabdomyosarcoma in an 18-months-old boy. Case(s) Presentation: An 18-months-old boy presented with complaint of difficult urinating since the last 2 months before presentation.
I Made Mahandita   +2 more
doaj   +1 more source

Cytotoxic capacity of IL-15-stimulated cytokine-induced killer cells against human acute myeloid leukemia and rhabdomyosarcoma in humanized preclinical mouse models [PDF]

open access: yes, 2012
Allogeneic stem cell transplantation (allo-SCT) has become an important treatment modality for patients with high-risk acute myeloid leukemia (AML) and is also under investigation for soft tissue sarcomas.
Wels, Winfried   +35 more
core   +1 more source

Proton beam therapy in paediatric cancer: Anticipating the opening of the Australian Bragg Centre for Proton Therapy and Research

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView., 2023
Summary Proton Beam Therapy (PBT) has the potential to improve paediatric cancer care by reducing radiation exposure and thus long‐term toxicities. Ethical concerns and debates surrounding the treatment, such as eligibility and accessibility, are ongoing in Australia. The Australian Bragg Centre for Proton Therapy and Research (ABCPTR) (named after Sir
Jeremy Khong   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy